Cited in:


This article has been cited by:

  1. 1
    Xiaomiao Zhang, Fengying Gao, Yunqi Yan, Zheng Ruan, Zhenwei Liu, Combination therapy with human umbilical cord mesenchymal stem cells and angiotensin-converting enzyme 2 is superior for the treatment of acute lung ischemia–reperfusion injury in rats, Cell Biochemistry and Function, 2015, 33, 2
  2. 2
    Xiahui Ge, Chong Bai, Is the mesenchymal stem cell a new hope for the management of COPD?, Current Respiratory Care Reports, 2014, 3, 3, 112


  3. 3
    Fabing Liu, Fengying Gao, Qian Li, Zhenwei Liu, The functional study of human umbilical cord mesenchymal stem cells harbouring angiotensin-converting enzyme 2 in rat acute lung ischemia-reperfusion injury model, Cell Biochemistry and Function, 2014, 32, 7
  4. You have free access to this content4
    Ying-Gang Zhu, Qi Hao, Antoine Monsel, Xiao-Mei Feng, Jae-Woo Lee, Adult stem cells for acute lung injury: Remaining questions and concerns, Respirology, 2013, 18, 5
  5. 5
    Tingfen Li, Yongmin Yan, Bingying Wang, Hui Qian, Xu Zhang, Li Shen, Mei Wang, Ying Zhou, Wei Zhu, Wei Li, Wenrong Xu, Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Liver Fibrosis, Stem Cells and Development, 2013, 22, 6, 845


  6. 6
    Feng Xu, Yue Hu, Jiebai Zhou, Xiangdong Wang, Mesenchymal stem cells in acute lung injury: are they ready for translational medicine?, Journal of Cellular and Molecular Medicine, 2013, 17, 8